Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy (opens in a new tab)
CompletedPhase 2/3
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsStemEx®
Dr. Mary Carol Territo, MD
NPI1427078039
- Publications
- 3
- Clinical trials
- 5
- Industry payments
- $2,398
- State licenses
- 2
- Year NPI issued
- 2006
- Practice address
- 200 Medical Plaza, Los Angeles, CA 90095-3075
- Practice phone
- Call (310) 206-6909
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Territo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mary Carol Territo is a hematologist and oncologist in Los Angeles, California
Dr. Territo practices in Los Angeles, California.
Dr. Territo's NPI, 1427078039, was assigned on July 20, 2006. Dr. Territo graduated from Wayne State University School Of Medicine in 1968. Dr. Territo holds California license C34130.
NPI and contact details
- NPI
- 1427078039NPI Registry (opens in a new tab)
- NPI enumeration date
- July 20, 2006
- NPI status
- Active
- Practice phone
- (310) 206-6909
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1968
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Mary Carol Territo's practice address is in Los Angeles, California
Dr. Territo's practice address in the NPI Registry is 200 Medical Plaza, Los Angeles, CA 90095-3075. The practice phone is (310) 206-6909.
- NPI Registry address200 Medical Plaza, Los Angeles, CA 90095-3075Phone(310) 206-6909
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Mary Carol Territo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Territo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Territo's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Territo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mary Carol Territo is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Territo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Territo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Territo's licenses on file in 2 states: California and Michigan.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Michigan license
Hematologists and oncologists near Dr. Territo
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mary Carol Territo has 3 publications on record
Dmand AI links 3 papers to Dr. Territo, published from 2012 to 2016. Dr. Territo's most frequent co-authors are Claudio Anasetti, MD, Juliet N. Barker, MBBS and Robert Howard Collins, MD.
Papers3
Years published2012 to 2016
Dr. Territo's most frequent co-authors
- Claudio Anasetti, MD1 shared paper
- Juliet N. Barker, MBBS1 shared paper
- Robert Howard Collins, MD1 shared paper
Recent publications by Dr. Territo
See who Dr. Territo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Territo works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mary Carol Territo has worked on 5 clinical trials
Dmand AI links Dr. Territo to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Hematologic Neoplasms, Hot Flashes and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Jonsson Comprehensive Cancer Center sponsors the most, 2.
Clinical trials with Dr. Territo by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Territo's trials
- Hematologic Neoplasms
- Hot Flashes
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Accelerated Phase
- Pdgfra-Associated Chronic Eosinophilic Leukemia
Investigators on the most trials with Dr. Territo
- Juliet N. Barker, MBBS1 shared trial
- Sonali Chaudhury, MD1 shared trial
- Celia L. Grosskreutz, MD1 shared trial
Recent clinical trials with Dr. Territo
Adult Double Cord Blood Transplant Study (opens in a new tab)
CompletedPhase 2
Hematologic NeoplasmsMyelodysplastic Syndromes
Pdgfra-Associated Chronic Eosinophilic LeukemiaLeukemia, Neutrophilic, ChronicItraconazoleVoriconazole
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia (opens in a new tab)
Status unknownPhase 3
Hot FlashesFeverLevofloxacinCefepime hydrochloride
Leukemia, Myeloid, Accelerated PhaseAnemia, Refractory, with Excess of Blastsautologous expanded mesenchymal stem cells OTI-010BusulfanCyclophosphamide
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mary Carol Territo received $2,398 in industry payments from 2017 to 2021
CMS Open Payments shows 8 general payments to Dr. Territo from 2 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 94% of the total. Merck Sharp & Dohme Corporation paid the most, $2,255.
General payments to Dr. Territo by program year, 2017 to 2021
General payments to Dr. Territo by kind, 2017 to 2021
$2.4Kin total
- Consulting fees$2,25594%
- Food and beverage$1436%
Companies that paid Dr. Territo the most, 2017 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mary Carol Territo has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Territo.
Awards and honors for Dr. Territo
- Undated
- Super Doc
- Whos Who
Source: Dmand AI Professional Profile Data
Dr. Mary Carol Territo graduated from Wayne State University School Of Medicine
Dr. Territo graduated from Wayne State University School Of Medicine in 1968.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Sources for Dr. Mary Carol Territo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mary Carol Territo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mary Carol Territo's NPI number?
Dr. Mary Carol Territo's NPI number is 1427078039. It was assigned on July 20, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mary Carol Territo?
Dr. Mary Carol Territo is a hematologist and oncologist in Los Angeles, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mary Carol Territo practice?
Dr. Territo practices at 200 Medical Plaza, Los Angeles, CA 90095-3075.
What is Dr. Mary Carol Territo's office phone number?
The practice phone on file for Dr. Territo is (310) 206-6909.
What is Dr. Mary Carol Territo's medical license number?
Dr. Territo holds California license C34130, one of the licenses on file in 2 states.
Which states has Dr. Mary Carol Territo been licensed in?
Dmand AI has state licenses on file for Dr. Territo in California (1972 to 2026) and Michigan.
Is Dr. Mary Carol Territo board certified?
Yes. Dr. Territo is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Mary Carol Territo go to medical school?
Dr. Territo graduated from Wayne State University School Of Medicine in 1968.
Has Dr. Mary Carol Territo received payments from drug or device companies?
CMS Open Payments shows $2,398 in general payments to Dr. Territo from 2 companies from 2017 to 2021. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Mary Carol Territo been practicing?
Dr. Territo graduated from medical school in 1968, 58 years ago.
Does Dr. Mary Carol Territo do research?
Dmand AI links 3 publications to Dr. Territo, published from 2012 to 2016. Dr. Territo has worked on 5 clinical trials.
Who does Dr. Mary Carol Territo publish with?
Dr. Territo's most frequent co-authors are Claudio Anasetti, MD (1 shared paper), Juliet N. Barker, MBBS (1 shared paper) and Robert Howard Collins, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card